Project Nootropic Ltd research brief
CIK 2080713
Generated Nov. 19, 2026, 7:18 a.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.
Current stored business address: LONDON United Kingdom. Reported legal jurisdiction: UNITED KINGDOM. These do not establish investor residence or where funds were deployed.
- July 15, 2026 · D/A · 0002080713-26-000002 · Source evidence
Reported offering amount: 1092000 USD. Reported amount sold: 1086720 USD.
- June 8, 2026 · D · 0002080713-26-000001 · Source evidence
Reported offering amount: 1067520 USD. Reported amount sold: 1067520 USD.
- Aug. 11, 2025 · D · 0002080713-25-000001 · Source evidence
Reported offering amount: 2000000 USD. Reported amount sold: 1920000 USD.
Reviewed offering links
- No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.
Citation: Form D Explorer, “Project Nootropic Ltd research brief,” CIK 2080713, retrieved Nov. 19, 2026, 7:18 a.m.. Cite the specific accessions used. No amounts have been summed.